Analysis of Chi Botanic
Chi Botanic, founded in 2017, is a pioneering company in the agriculture, biotechnology, and food and beverage industries. With the slogan "We're developing the world's first synthetic biology pipeline to leverage the power of the plant cell," Chi Botanic is focused on leveraging cutting-edge technology to revolutionize these sectors.
The company recently secured a $175.00K grant investment on 04 May 2023, with the backing of prominent investors including the U.S. Department of Agriculture and the National Institute of Food and Agriculture.
Headquartered in the United States, Chi Botanic is committed to becoming a leader in synthetic biology and is well-positioned to make significant advancements in the utilization of plant cells.
As Chi Botanic continues to make strides in its mission to harness the potential of plant cell technology, its innovative approach and strong financial backing make it an intriguing prospect for potential investors looking to support groundbreaking advancements in agriculture and biotechnology.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | $175.00K | 2 | U.S. Department of Agriculture, National Institute of Food and Agriculture | 04 May 2023 |
Convertible Note | $850.00K | 1 | 27 Nov 2021 | |
Convertible Note | $950.00K | 5 | Advisors.fund, Mayfield Fund | 06 Mar 2020 |
Pre Seed Round | $250.00K | 2 | 05 Nov 2019 |
No recent news or press coverage available for Chi Botanic.